Memory Complaints After COVID Linked to Mood, Not Cognition
A small study found adults reporting post-COVID memory problems showed no objective cognitive deficits but higher depression and anxiety scores.
Updated on Nov. 2, 2026 in Alzheimer’s
Adults who reported worsening memory or concentration after SARS-CoV-2 infection performed normally on standardized cognitive testing. Those complaints were, however, associated with significantly higher depression and anxiety symptoms than in control participants.
Why it matters
The findings suggest that subjective memory complaints after COVID-19 may reflect mood symptoms rather than measurable brain function changes. This could shape how clinicians approach patients with lingering cognitive concerns.
Among 62 participants tested with the MATRICS Consensus Cognitive Battery and CVLT-3, cases averaged 5.53 on the BDI Cognitive-Affective scale versus 1.35 for controls (P < .001). Carrier rates for the APOE epsilon 4 allele were 41% among cases and 6% among controls, but whether this genetic link affects long-term outcomes is not yet known.
The players
Journal of Psychiatric Research
A peer-reviewed academic journal publishing research on psychiatric disorders, mood, and related neuroscience.
The details
Researchers compared adults with self-reported post-COVID memory or concentration problems against control individuals, all assessed more than 12 weeks after infection. Cases also showed elevated soluble CD14, an inflammation marker, and were more likely to carry the APOE epsilon 4 allele. In the final models, depression and APOE status independently predicted depression scores, while anxiety alone significantly predicted anxiety scores (P = .004).
Timeline
Participants were assessed more than 12 weeks after SARS-CoV-2 infection.
The study was published online October 27 in the Journal of Psychiatric Research.
Big Picture
The study adds to ongoing long COVID research into whether persistent neurological symptoms reflect true brain changes or psychological factors. Its findings point toward mood as a plausible driver of subjective memory complaints in this population.
Adults concerned about memory after COVID-19 may find that treating depression or anxiety is a reasonable first step before pursuing cognitive training or memory medications. Clinicians may want to screen for mood symptoms alongside any cognitive concerns.
The takeaway
Persistent memory worries after COVID-19 may be tied to mood rather than brain damage, so evaluating depression and anxiety could be a practical starting point. Anyone with lingering concerns should discuss both cognitive and emotional symptoms with a clinician.
Further reading
For broader context on memory decline and dementia research, explore our Alzheimer's coverage.
Source note: This article includes information reported by Medscape.
